Sperm Count Test

Global Sperm Count Test Market to Reach US$3.0 Billion by 2030

The global market for Sperm Count Test estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Instrument, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Reagents & Consumables segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$614.0 Million While China is Forecast to Grow at 7.7% CAGR

The Sperm Count Test market in the U.S. is estimated at US$614.0 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$589.4 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Sperm Count Test Market – Key Trends & Drivers Summarized

Why Is the Demand for Sperm Count Testing Rising in Reproductive Health?
Sperm count tests are essential diagnostic tools in male fertility assessment, helping detect low sperm concentration (oligospermia), motility issues, and abnormal morphology—all of which influence conception outcomes. These tests are foundational to infertility workups in clinical settings and are increasingly being adopted in home-use formats. As male infertility becomes a more recognized and openly discussed health issue, the demand for accurate, accessible sperm count testing is steadily increasing worldwide.

Lifestyle factors such as obesity, stress, environmental toxin exposure, smoking, and delayed parenthood are contributing to a global decline in average sperm quality. This trend, coupled with greater public awareness of reproductive health, is prompting more men to proactively monitor their fertility status. As a result, sperm count testing is transitioning from a clinic-based, specialist procedure to a mainstream wellness check, supported by direct-to-consumer (DTC) testing platforms and telehealth integration.

How Are Innovations Enhancing the Accuracy and Accessibility of Sperm Testing?
Technological advancements are redefining the sperm testing experience through portable, user-friendly, and AI-enhanced diagnostic tools. At-home test kits now incorporate smartphone-based microscopy, cloud-based data interpretation, and digital tracking features that provide users with quantitative sperm count, motility percentages, and morphology scoring—all in real time. These tests enable men to monitor their fertility from the privacy of their homes, reducing stigma and promoting early intervention.

In clinical settings, automated semen analyzers equipped with computer-assisted sperm analysis (CASA) systems offer high-throughput, objective evaluations. AI algorithms improve consistency in detecting subtle abnormalities, enhancing lab reliability. New biosensor technologies and lab-on-chip platforms are also being developed for ultra-sensitive, point-of-care sperm diagnostics. Additionally, fertility clinics are integrating these tests with broader hormonal and genetic panels to provide comprehensive male reproductive health profiling.

Which End-Users and Regional Markets Are Driving Market Expansion?
Fertility clinics and andrology labs remain the largest institutional users of sperm count tests, where accuracy and scalability are critical. However, home-use kits are the fastest-growing segment, targeting men planning parenthood, undergoing IVF, or concerned about fertility impacts from health conditions or medications. Online platforms offering fertility tracking, counseling, and digital health subscriptions are increasingly bundling sperm count testing with reproductive wellness services.

North America and Europe are leading regions in both clinical adoption and consumer-driven fertility testing, owing to high awareness, access to reproductive healthcare, and growing demand for assisted reproductive technologies (ART). Asia-Pacific is witnessing rapid growth due to rising infertility rates, urbanization, and growing acceptance of home diagnostics, especially in India, China, and Japan. Digital health expansion in Latin America and the Middle East is also beginning to drive home-use sperm test demand, particularly among urban and tech-savvy demographics.

The Growth in the Sperm Count Test Market Is Driven by Several Factors…
It is driven by increasing awareness of male infertility, lifestyle-related sperm quality decline, and growing adoption of home diagnostic technologies. The rise of at-home health testing and fertility tracking apps has made sperm count testing more accessible and socially acceptable, broadening its consumer base. Technological innovations—including smartphone integration, AI-powered analysis, and point-of-care biosensors—are enhancing accuracy, usability, and affordability across both clinical and direct-to-consumer channels.

The expansion of fertility treatment markets, delayed parenthood trends, and greater emphasis on male reproductive health are also catalyzing demand. Additionally, partnerships between diagnostics companies and telehealth platforms are creating integrated reproductive health solutions that include sperm testing as a core component. As men increasingly take proactive steps to monitor and manage their fertility, the sperm count test market is positioned for continued growth across diagnostic, preventive, and wellness-driven healthcare landscapes.

SCOPE OF STUDY:

The report analyzes the Sperm Count Test market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Instrument, Reagents & Consumables, Kits); Technique (Microscopy, Chromatographic Immunoassay & Colorimetric Reaction, Other Techniques); Age Group (Below 35 Yrs, 35 - 40 Yrs, Above 40 Yrs); End-User (Hospitals, Fertility Centers, Diagnostic Laboratories, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AB ANALITICA s.r.l.
• Andrology Solutions
• Artron Laboratories Inc.
• bioMérieux SA
• ContraVac, Inc.
• CooperSurgical, Inc.
• DNA Diagnostics Center
• DxNow
• ExSeed Health
• Fertility Focus Inc.
• Hamilton Thorne
• Medical Electronic Systems
• MICROPTIC S.L.
• Mojo Fertility
• Olympus Corporation
• Ro
• Sandstone Diagnostics
• SwimCount (MotilityCount ApS)
• Thermo Fisher Scientific Inc.
• Vitrolife AB

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.